Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Dovitinib (TKI-258) for Translational Cancer Assays
2026-08-21
Dovitinib (TKI-258) connects multitarget RTK inhibition with practical measurements of pathway suppression, viability, and apoptosis. This workflow also shows how radiopathomics concepts can help stratify response phenotypes without mistaking a computational biomarker for direct drug evidence.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-20
The reference study develops a PEG-free, hyaluronate-integrated lipid nanoparticle for topical delivery of PTEN mRNA into melanoma-bearing skin. Its preclinical results connect localized PTEN restoration with reduced tumor-cell viability, immunogenic cell death, tumor growth suppression, and enhanced antitumor immune activation.
-
SB203580 for p38 MAPK Assay Workflows
2026-08-20
Learn how to use SB203580 to dissect p38 MAPK-dependent phosphorylation, inflammatory signaling, and stress responses without confusing pathway inhibition with reduced p38 activation. This workflow-centered guide combines concentration planning, orthogonal controls, neuroinflammation applications, and troubleshooting for more interpretable cell-based experiments.
-
Leucovorin Calcium for Tumor Assembloid Rescue
2026-08-19
A translational framework for using Leucovorin Calcium, or calcium folinate, as a mechanistic rescue control in methotrexate studies, with emphasis on patient-derived gastric cancer assembloids, assay design, resistance biology, and reproducible formulation practices.
-
Leucovorin Calcium in Assembloid Rescue Assays
2026-08-19
Leucovorin Calcium, also known as calcium folinate, can function as a mechanistic rescue control in methotrexate studies. This guide shows how to use paired gastric cancer organoid and assembloid models to distinguish cell-intrinsic folate sensitivity from microenvironment-dependent drug response.
-
Leucovorin Calcium in Tumor Assay Design
2026-08-18
Leucovorin Calcium, or calcium folinate, can do more than rescue methotrexate-stressed cells. This article shows how to use folate rescue as a context-sensitive assay control in patient-derived gastric cancer assembloids and interpret stromal effects without overstating the evidence.
-
Clodronate Liposomes: In Vivo Workflow Guide
2026-08-18
Clodronate Liposomes enable controlled in vivo macrophage depletion to test whether macrophages drive tumor growth, inflammation, or treatment resistance. This guide translates recent colorectal cancer immunology findings into practical controls, assay choices, optimization steps, and interpretation safeguards.
-
TCF25 Links Glucose Starvation to Lysosomal Cell Death
2026-08-17
Ren et al. identify TCF25 as a nutrient-stress regulator that enhances V-ATPase-dependent lysosomal acidification during glucose deprivation. The study shows that this response initially supports autophagy and ATP production but, under prolonged starvation, drives ferritinophagy, lysosomal membrane permeability, and lysosome-dependent cell death, with implications for ischemia-reperfusion injury research.
-
Ibuprofen Toxicology and Biodegradation: Key Findings
2026-08-17
The 2023 Molecules review frames ibuprofen as an emerging contaminant by connecting widespread use, environmental persistence, aquatic toxicity, and incomplete removal in wastewater systems. Its central contribution is an integrated assessment of toxicological evidence and bacterial biodegradation as a possible remediation direction, while highlighting major gaps in monitoring, standardization, and ecological risk assessment.
-
Ibuprofen Toxicology and Biodegradation: Key Insights
2026-08-16
The 2023 Molecules review frames ibuprofen as both a widely used COX-targeting medicine and an emerging environmental contaminant, linking pharmaceutical consumption with aquatic toxicity and limited environmental removal. Its main practical contribution is the integration of toxicological evidence with bacterial biodegradation strategies, while highlighting important gaps in monitoring, treatment, and ecological risk assessment.
-
Rice 5hmC Reprogramming During Drought
2026-08-15
Yan et al. established the first single-base-resolution map of 5-hydroxymethylcytosine in rice and showed that drought changes both its abundance and genomic distribution. The study links promoter and gene-body 5hmC patterns with distinct transcriptional outcomes, providing a framework for interpreting plant drought response epigenetics while highlighting important limits on causal inference.
-
Pepstatin A for Reliable Cell Assays
2026-08-14
Learn how Pepstatin A (SKU A2571) can clarify protease-dependent changes in viability, proliferation, cytotoxicity, endothelial, viral, and osteoclast models. This scenario-based guide covers mechanism, compatibility, dosing, stock preparation, interpretation, and practical supplier selection.
-
Leucovorin Calcium as a Rescue-Axis Assay Tool
2026-08-14
Leucovorin Calcium, also called calcium folinate, can serve as more than a methotrexate rescue reagent. This article presents a rescue-axis framework for interpreting folate metabolism, stromal protection, and drug-response heterogeneity in patient-derived gastric cancer assembloid assays.
-
Fucoidan Workflows for Mechanistic Cancer Research
2026-08-13
Build reproducible Fucoidan experiments around solvent control, orthogonal apoptosis readouts, and immune or angiogenesis endpoints. This workflow also shows how a herpesvirus membrane-fusion study can sharpen assay design without overstating Fucoidan’s antiviral evidence.
-
BGJ398 in FGFR and Developmental Assays
2026-08-13
BGJ398 (NVP-BGJ398) combines nanomolar FGFR1/2/3 activity with a selectivity profile suited to receptor-dependence studies. This article translates that profile into oncology, signaling, and developmental-tissue workflows while emphasizing controls, dosing logic, and troubleshooting.